Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,644 SEK | -0.06% | -1.88% | +21.43% |
May. 17 | Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial | RE |
May. 16 | AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial | MT |
- Stock Market
- Equities
- AZN Stock
- AZN Stock
- News AstraZeneca PLC
- MarketScreener Strategies